Infantile acute erythrodermic pustular psoriasis with a good response to acitretin monotherapy

Acute Pustular Psoriasis

was stable, his skin became irritable and hot with extensive reddening. Though in bed in a warm room he felt cold. During the next three days the skin became tender, and large areas of pustulation developed. Subsequently there was widespread peeling of the skin, and crusting developed on the face and neck. On admission to hospital there was generalized cutaneous erythema and scleral jaundice. T...

Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.

Generalised pustular psoriasis: response to topical calcipotriol.

Blastomycosis-like Pyoderma with Good Response to Acitretin

Blastomycosis-like pyoderma is a rare, vegetating skin lesion that is an unusual exaggerated tissue reaction possibly to prolonged primary or secondary bacterial infection. We report a case of blastomycosis-like pyoderma in a man with Down syndrome, diabetes mellitus and hypothyroidism who responsed poorly to conventional therapies, including antibiotics and correction of predisposing factors f...

Erythrodermic Psoriasis Treated with Apremilast

Erythroderma is a rare potentially deadly exfoliative dermatitis characterized by diffuse cutaneous erythema which may be associated with multi-organ dysfunction. Therefore, it is imperative to recognize and treat it promptly. Erythrodermic psoriasis is the most common form of erythroderma. Management of this condition is largely based on aggressive supportive care and the use of anti-inflammat...

Erythrodermic Psoriasis Treated with Golimumab: A Case Report

Erythrodermic psoriasis (EP) is a very severe variant of psoriasis whose management poses a challenge to physicians, as currently available therapies often provide unsatisfactory results. Many biologics have been used to treat chronic plaque psoriasis, the most common form of psoriasis; however, their effectiveness for EP is poorly understood. A recently developed biologic, golimumab, has been ...